Literature DB >> 11035762

Contribution of plasmid-encoded fimbriae and intimin to capacity of rabbit-specific enteropathogenic Escherichia coli to attach to and colonize rabbit intestine.

E O Krejany1, T H Grant, V Bennett-Wood, L M Adams, R M Robins-Browne.   

Abstract

Attachment to the intestinal mucosa is an essential step in the pathogenesis of diarrhea caused by enteropathogenic Escherichia coli (EPEC). Fimbriae and intimin, the outer membrane protein product of the chromosomal eae gene, contribute to this process, but their relative roles and the nature of their interaction are not known. The aim of this study was to determine the relative contribution of plasmid-encoded fimbriae, termed Ral, and intimin to the capacity of rabbit-specific EPEC (REPEC) to attach to the intestinal mucosa of rabbits. To achieve this, we constructed a series of mutants in REPEC strain 83/39 (O15:H-), in which the ralE and eae genes were insertionally inactivated. These strains were then inoculated into ligated loops of rabbit ileum, which were resected 18 h later and examined by light and electron microscopy. The results showed that intimin, but not Ral, is essential for the elicitation of attaching-effacing lesions by REPEC. Nevertheless, a delta eae Ral-bearing mutant adhered to the intestinal epithelium to the same extent as its eae-positive parent and far more extensively than an eae(+) delta ral strain. To examine the contribution of Ral and intimin to colonization of rabbit intestine, we fed these strains to weanling rabbits, which were killed 4 days later, so that the number of bacteria in various regions of the intestine could be determined. The results indicated that strain 83/39 requires both Ral and intimin to colonize the intestine successfully and that a delta eae delta ralE double mutant was incapable of colonizing the intestine. Taken together, these findings indicate that Ral and intimin act independently as adhesion factors of REPEC strain 83/39 and that this strain carries no other significant colonization factor. When both Ral and intimin are present, they appear to act cooperatively, with Ral-mediated adhesion preceding that mediated by intimin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035762      PMCID: PMC97736          DOI: 10.1128/IAI.68.11.6472-6477.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  The type IV bundle-forming pilus of enteropathogenic Escherichia coli undergoes dramatic alterations in structure associated with bacterial adherence, aggregation and dispersal.

Authors:  S Knutton; R K Shaw; R P Anantha; M S Donnenberg; A A Zorgani
Journal:  Mol Microbiol       Date:  1999-08       Impact factor: 3.501

Review 2.  Enteropathogenic Escherichia coli.

Authors:  M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

3.  Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli.

Authors:  R F Wang; S R Kushner
Journal:  Gene       Date:  1991-04       Impact factor: 3.688

4.  Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa.

Authors:  S Knutton; D R Lloyd; A S McNeish
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

5.  A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.

Authors:  V L Miller; J J Mekalanos
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

6.  A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.

Authors:  A E Jerse; J Yu; B D Tall; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2.

Authors:  O Marchès; J P Nougayrède; S Boullier; J Mainil; G Charlier; I Raymond; P Pohl; M Boury; J De Rycke; A Milon; E Oswald
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Examination of archetypal strains of enteropathogenic Escherichia coli for properties associated with bacterial virulence.

Authors:  R M Robins-Browne; W C Yam; L E O'Gorman; K A Bettelheim
Journal:  J Med Microbiol       Date:  1993-03       Impact factor: 2.472

9.  Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.

Authors:  M S Donnenberg; C O Tacket; S P James; G Losonsky; J P Nataro; S S Wasserman; J B Kaper; M M Levine
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model.

Authors:  M S Donnenberg; S Tzipori; M L McKee; A D O'Brien; J Alroy; J B Kaper
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more
  11 in total

1.  Control of bacterial virulence by the RalR regulator of the rabbit-specific enteropathogenic Escherichia coli strain E22.

Authors:  Yogitha N Srikhanta; Dianna M Hocking; Matthew J Wakefield; Ellen Higginson; Roy M Robins-Browne; Ji Yang; Marija Tauschek
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

Review 2.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

3.  Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli.

Authors:  Stephen Doughty; Joan Sloan; Vicki Bennett-Wood; Marcus Robertson; Roy M Robins-Browne; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection.

Authors:  Bruce A Vallance; Wanyin Deng; Leigh A Knodler; B Brett Finlay
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Predominance of afr2 and ral fimbrial genes related to those encoding the K88 and CS31A fimbrial adhesins in enteropathogenic Escherichia coli isolates from rabbits with postweaning diarrhea in Central Europe.

Authors:  Mohamed A Dow; István Tóth; Pavel Alexa; Michael Davies; Anna Malik; Eric Oswald; Béla Nagy
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  Contribution of long polar fimbriae to the virulence of rabbit-specific enteropathogenic Escherichia coli.

Authors:  Hayley J Newton; Joan Sloan; Vicki Bennett-Wood; Louise M Adams; Roy M Robins-Browne; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 7.  Initial adherence of EPEC, EHEC and VTEC to host cells.

Authors:  Marjorie Bardiau; Mihai Szalo; Jacques G Mainil
Journal:  Vet Res       Date:  2010-04-29       Impact factor: 3.683

8.  RegR virulence regulon of rabbit-specific enteropathogenic Escherichia coli strain E22.

Authors:  Yogitha N Srikhanta; Dianna M Hocking; Judyta Praszkier; Matthew J Wakefield; Roy M Robins-Browne; Ji Yang; Marija Tauschek
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

9.  Contribution of a novel gene, rpeA, encoding a putative autotransporter adhesin to intestinal colonization by rabbit-specific enteropathogenic Escherichia coli.

Authors:  Denisse L Leyton; Louise M Adams; Michelle Kelly; Joan Sloan; Marija Tauschek; Roy M Robins-Browne; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2007-07-09       Impact factor: 3.441

10.  Intimin, tir, and shiga toxin 1 do not influence enteropathogenic responses to shiga toxin-producing Escherichia coli in bovine ligated intestinal loops.

Authors:  Mark P Stevens; Olivier Marchès; June Campbell; Veronika Huter; Gad Frankel; Alan D Phillips; Eric Oswald; Timothy S Wallis
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.